These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15850508)

  • 41. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
    Darwish Murad S; Kim WR; de Groen PC; Kamath PS; Malinchoc M; Valla DC; Janssen HL
    Liver Transpl; 2007 Jun; 13(6):867-74. PubMed ID: 17539007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.
    Wong VW; Chim AM; Wong GL; Sung JJ; Chan HL
    Liver Transpl; 2007 Sep; 13(9):1228-35. PubMed ID: 17763399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.
    Dhiman RK; Jain S; Maheshwari U; Bhalla A; Sharma N; Ahluwalia J; Duseja A; Chawla Y
    Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variation of the MELD score as a predictor of death on the waiting list for liver transplantation.
    Gheorghe L; Iacob S; Iacob R; Gheorghe C; Popescu I
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):267-72. PubMed ID: 17925920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E; Senzolo M; Patch D; Kwong K; Nikolopoulou V; Leandro G; Shaw S; Burroughs AK
    Aliment Pharmacol Ther; 2006 Apr; 23(7):883-93. PubMed ID: 16573791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P; Desai N; Alexander J; Singh DP; Sawant P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MELD accurately predicts mortality in patients with alcoholic hepatitis.
    Dunn W; Jamil LH; Brown LS; Wiesner RH; Kim WR; Menon KV; Malinchoc M; Kamath PS; Shah V
    Hepatology; 2005 Feb; 41(2):353-8. PubMed ID: 15660383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY; Yu ML; Hsieh MY; Lee LP; Hou NJ; Huang JF; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Chuang WL
    Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition.
    Putchakayala K; Polensky S; Fitzhugh J; Cohran V; Buchman A; Fryer J
    JPEN J Parenter Enteral Nutr; 2009; 33(1):55-61. PubMed ID: 18941030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence-based incorporation of serum sodium concentration into MELD.
    Biggins SW; Kim WR; Terrault NA; Saab S; Balan V; Schiano T; Benson J; Therneau T; Kremers W; Wiesner R; Kamath P; Klintmalm G
    Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model for end-stage liver disease can predict very early outcome after liver transplantation.
    Briceño J; Sánchez-Hidalgo JM; Naranjo A; Ciria R; Pozo JC; Luque A; de la Mata M; Rufián S; López-Cillero P
    Transplant Proc; 2008 Nov; 40(9):2952-4. PubMed ID: 19010157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.
    Srikureja W; Kyulo NL; Runyon BA; Hu KQ
    J Hepatol; 2005 May; 42(5):700-6. PubMed ID: 15826720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.
    Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS
    Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.